Interactions in vitro between polyenes and imidazoles against yeasts

Journal of Antimicrobial Chemotherapy

Volumn 27, Issue 4, 1991, Pages 491-506

  Petron, M A ^a   Rogers, T R ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MEPARTRICIN; MICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG CONCENTRATION; DRUG INTERACTION; DRUG POTENTIATION; NONHUMAN; PRIORITY JOURNAL; YEAST;

ANTIFUNGAL AGENTS; CULTURE MEDIA; DRUG INTERACTIONS; IMIDAZOLES; MICROBIAL SENSITIVITY TESTS; POLYENES; SUPPORT, NON-U.S. GOV'T; YEASTS;

EID: 0025759856     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/27.4.491     Document Type: Article

References (40)

1. Ansehn, S. & Nilsson, L. (1984). Direct membrane-damaging effect of ketoconazole and tioconazole on Candida albicans demonstrated by bioluminescent assay of ATP. Antimicrobial Agents and Chemotherapy 26, 22-5.
2. Barry, A. L. & Sabath, L. D. (1974). Special tests: bactericidal activity and activity of antibiotics in combination. In Manual of Clinical Microbiology, 2nd edn (Lennette, E. H., Spaulding, E. H. & Truant, J. P., Eds), pp. 431-5. American Society for Microbiology, Washington, DC.
3. Beggs, W. H. (1983). Comparison of miconazole—and ketoconazole-induced release of K + from Candida species. Journal of Antimicrobial Chemotherapy 11, 381-3.
4. Beggs, W. H., Sarosi, G. A. & Steele, N. M. (1976). Inhibition of potentially pathogenic yeastlike fungi by clotrimazole in combination with 5-fluorocytosine or amphotericin B. Antimicrobial Agents and Chemotherapy 9, 863-5.
5. Berenbaum, M. C. (1978). A method for testing for synergy with any number of agents. Journal of Infectious Diseases 137, 122-30.
6. Block, E. R. & Bennett, J. E. (1973). The combined effect of 5-fluorocytosine and amphotericin B in the therapy of murine cryptococcosis. Proceedings of the Society for Experimental Biology and Medicine 142, 476-80.
7. Block, E. R., Bennett, J. E., Livoti, L. G., Klein, W. J., MacGregor, R. R. & Henderson, L. (1974). Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man. Annals of Internal Medicine 80, 613-7.
8. Borgers, M. (1980). Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives. Reviews of Infectious Diseases 2, 520-34.
9. Borgers, M. & Van den Bossche, H. (1982). The mode of action of antifungal drugs. In Ketoconazole in the Management of Fungal Disease (Levine, H. B., Ed.), pp. 25-47. ASIS Press, Auckland.
10. Brajtburg, J., Kobayashi, D., Medoff, G. & Kobayashi, G. S. (1982). Antifungal action of amphotericin B in combination with other polyene or imadazole antibiotics. Journal of Infectious Diseases 146, 138-46.
11. Brajtburg, J., Powderly, W. G., Kobayashi, G. S. & Medoff, G. (1990). Amphotericin B: current understanding of mechanisms of action. Antimicrobial Agents and Chemotherapy 34, 183-8.
12. Cosgrove, R. F., Beezer, A. E. & Miles, R. J. (1978). In vitro studies of amphotericin B in combination with the imidazole antifungal compounds clotrimazole and miconazole. Journal of Infectious Diseases 138, 681-5.
13. Davis, S. J. & Donovan, W. H. (1979). Combined intravenous miconazole and intrathecal amphotericin B for treatment of disseminated coccidioidomycosis. Chest 76, 235-6.
14. Dupont, B. & Drouhet, E. (1977). Methode rapide de la determination de la synergie antifongique. Bulletin de la Societe Franfaise de Mycologie Medicate 6, 291-4.
15. Dupont, B. & Drouhet, E. (1979). In vitro synergy and antagonism of antifungal agents against yeast-like fungi. Postgraduate Medical Journal 55, 683-6.
16. Gale, E. F., Johnson, A. M., Kerridge, D. & Koh, T. Y. (1975). Factors affecting the changes in amphotericin sensitivity of Candida albicans during growth. Journal of General Microbiology 87, 20-36.
17. Graybill, J. R., Williams, D. M., Van Cutsem, E. & Drutz, D. J. (1980). Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole. Reviews of Infectious Diseases 2, 551-8.
18. Jawetz, E. (1968). Combined antibiotic action: some definitions and correlations between laboratory and clinical results. Antimicrobial Agents and Chemotherapy—1967, 203-9.
19. Krogstad, D. J. & Moellering, R. C. (1980). Combinations of antibiotics, mechanisms of interaction against bacteria. In Antibiotics in Laboratory Medicine (Lorian, V., Ed.), pp. 298-341. Williams & Wilkins, London.
20. McAllister, T. A. (1974). Treatment of osteomyelitis. British Journal of Hospital Medicine 12, 535-45.
21. Odds, F. C. (1979). Problems in the laboratory assessment of antifungal activity. Postgraduate Medical Journal 55, 677-80.
22. Odds, F. C. (1982). Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro. Antimicrobial Agents and Chemotherapy 22, 763-70.
23. Petrou, M. A. (1989). A Study of the Effects of Antimicrobial Agents and Serum on Candida albicans and Related Yeasts. PhD Thesis, University of London.
24. Petrou, M. A. & Rogers, T. R. (1985). A comparison of the activity of mepartricin and amphotericin B against yeasts. Journal of Antimicrobial Chemotherapy 16, 169-77.
25. Petrou, M. A. & Rogers, T. R. (1988). In-vitro activity of antifungal agents in combination with four quinolones. Drugs under Experimental and Clinical Research 14, 9-18.
26. Pfaller, M. A., Burmeister, L., Bartlett, M. S. & Rinaldi, M. G. (1988). Multicenter evaluation of four methods of yeast inoculum preparation. Journal of Clinical Microbiology 26, 1437-41.
27. Pirt, S. J. & Callows, D. S. (1964). Continuous-flow culture of ERK and L types of mammalian cells. Experimental Cell Research 33, 413-21.
28. Plempel, M. (1979). Pharmacokinetics of imidazole antimycotics. Postgraduate Medical Journal 55, 662-6.
29. Saunders, A. M., Goolden, A. W. G. & Darrell, A. H. (1978). Cryptococcosis: survival attributed to combination antifungal treatment. British Medical Journal i, 1030-1.
30. Schacter, L. P., Owellen, R. J., Rathbun, H. K. & Buchanan, B. (1976). Antagonism between miconazole and amphotericin B. Lancet ii, 318.
31. Schaffner, A. & Frick, P. G. (1985). The effects of ketoconazole on amphotericin B in a model of disseminated aspergillosis. Journal of Infectious Diseases 151, 902-10.
32. Scholer, H. J. (1980). Flucytosine. In Antifungal Chemotherapy (Speller, D. C. E., Ed.), pp. 35-106. Wiley, Chichester.
33. Shadomy, S., Wagner] G., Espinel-Ingroff, A. & Davis, B. A. (1975). In vitro studies with combinations of 5-fluorocytosine and amphotericin B. Antimicrobial Agents and Chemotherapy 8, 117-21.
34. Sud, I. J., Chou, D.-L. & Feingold, D. S. (1979). Effect of free fatty acids on liposome susceptibility to imidazole antifungals. Antimicrobial Agents and Chemotherapy 16, 660-3.
35. Sud, I. J. & Feingold, D. S. (1981). Mechanisms of action of the antimycotic imidazoles. Journal of Investigative Dermatology 76, 438-41.
36. Sud, I. J. & Feingold, D. S. (1983). Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans. Antimicrobial Agents and Chemotherapy 23, 185-7.
37. Swamy, K. H. S., Sirsi, M. & Rao, G. R. (1974). Studies on the mechanism of action of miconazole: effect of miconazole on respiration and cell permeability of Candida albicans. Antimicrobial Agents and Chemotherapy 5, 420-5.
38. Thomas, A. H. (1986). Suggested mechanisms for the antimycotic activity of the polyene antibiotics and the TV-substituted imidazoles. Journal of Antimicrobial Chemotherapy 17, 269-79.
39. Uno, J., Shigematsu, M. L. & Arai, T. (1982). Primary site of action of ketoconazole on Candida albicans. Antimicrobial Agents and Chemotherapy 21, 912-8.
40. Yamaguchi, H. & Iwata, K. (1979). Effect of fatty acyl group and sterol composition on sensitivity of lecithin liposomes to imidazole antimycotics. Antimicrobial Agents and Chemotherapy 15, 706-11.